HOB Biotech (China) Buy Hold or Sell Recommendation
| 688656 Stock | 111.45 1.35 1.23% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding HOB Biotech Group is 'Hold'. Macroaxis provides HOB Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 688656 positions.
Check out HOB Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as HOB and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards HOB Biotech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
HOB |
Execute HOB Biotech Buy or Sell Advice
The HOB recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on HOB Biotech Group. Macroaxis does not own or have any residual interests in HOB Biotech Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute HOB Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Strong | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
HOB Biotech Trading Alerts and Improvement Suggestions
| HOB Biotech Group is way too risky over 90 days horizon | |
| HOB Biotech Group appears to be risky and price may revert if volatility continues | |
| HOB Biotech Group is unlikely to experience financial distress in the next 2 years | |
| About 78.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Following recent decline, HOB Biotech Group Corp.,Ltds top shareholder CEO John Li sees holdings value drop by 12 percent - Simply Wall St |
HOB Biotech Returns Distribution Density
The distribution of HOB Biotech's historical returns is an attempt to chart the uncertainty of HOB Biotech's future price movements. The chart of the probability distribution of HOB Biotech daily returns describes the distribution of returns around its average expected value. We use HOB Biotech Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of HOB Biotech returns is essential to provide solid investment advice for HOB Biotech.
| Mean Return | 2.68 | Value At Risk | -6.47 | Potential Upside | 20.00 | Standard Deviation | 7.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of HOB Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
HOB Biotech Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (10.5M) | (2.3M) | (6.3M) | (19.6M) | (23.4M) | (22.2M) | |
| Change In Cash | 24.2M | (31.9M) | 391.0M | (296.6M) | 10.2M | 14.9M | |
| Free Cash Flow | 33.8M | 1.2M | (63.1M) | (161.9M) | (75.3M) | (71.6M) | |
| Change In Working Capital | (10.7M) | (2.8M) | 2.5M | (18.8M) | 3.8M | 4.0M | |
| Begin Period Cash Flow | 66.5M | 90.8M | 58.8M | 449.9M | 153.3M | 118.3M | |
| Other Cashflows From Financing Activities | 55M | 60M | 504.8M | 43.8M | 50.4M | 47.9M | |
| Depreciation | 13.3M | 15.4M | 24.5M | 32.5M | 39.5M | 20.3M | |
| Other Non Cash Items | 2.1M | (11.0M) | (8.4M) | 2.9M | 10.5M | 11.0M | |
| Dividends Paid | 41.5M | 49.2M | 19.8M | 34.7M | 20.8M | 23.5M | |
| Capital Expenditures | 34.8M | 57.0M | 167.9M | 220.2M | 178.0M | 99.4M | |
| Total Cash From Operating Activities | 68.6M | 58.2M | 104.8M | 58.3M | 102.7M | 64.3M | |
| Net Income | 63.8M | 56.6M | 86.2M | 41.7M | 47.9M | 49.8M | |
| Total Cash From Financing Activities | (10.5M) | (55.3M) | 441.0M | (10.9M) | (12.5M) | (11.9M) | |
| End Period Cash Flow | 90.8M | 58.8M | 449.9M | 153.3M | 163.5M | 138.8M |
HOB Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HOB Biotech or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HOB Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HOB stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.55 | |
β | Beta against Dow Jones | 1.17 | |
σ | Overall volatility | 8.25 | |
Ir | Information ratio | 0.33 |
HOB Biotech Volatility Alert
HOB Biotech Group is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure HOB Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact HOB Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.HOB Biotech Fundamentals Vs Peers
Comparing HOB Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze HOB Biotech's direct or indirect competition across all of the common fundamentals between HOB Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as HOB Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of HOB Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing HOB Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare HOB Biotech to competition |
| Fundamentals | HOB Biotech | Peer Average |
| Return On Equity | 0.0439 | -0.31 |
| Return On Asset | 0.0266 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 6.95 B | 16.62 B |
| Shares Outstanding | 63.06 M | 571.82 M |
| Shares Owned By Insiders | 77.69 % | 10.09 % |
| Shares Owned By Institutions | 3.10 % | 39.21 % |
| Price To Book | 8.61 X | 9.51 X |
| Price To Sales | 17.44 X | 11.42 X |
| Revenue | 394.41 M | 9.43 B |
| Gross Profit | 320.16 M | 27.38 B |
| EBITDA | 78.62 M | 3.9 B |
| Net Income | 47.92 M | 570.98 M |
| Total Debt | 54.83 M | 5.32 B |
| Book Value Per Share | 12.95 X | 1.93 K |
| Cash Flow From Operations | 102.69 M | 971.22 M |
| Earnings Per Share | 0.56 X | 3.12 X |
| Number Of Employees | 550 | 18.84 K |
| Beta | 0.21 | -0.15 |
| Market Capitalization | 7 B | 19.03 B |
| Total Asset | 949.26 M | 29.47 B |
| Retained Earnings | 162.13 M | 9.33 B |
| Working Capital | 192.46 M | 1.48 B |
| Annual Yield | 0 % | |
| Net Asset | 949.26 M | |
| Last Dividend Paid | 0.4 |
HOB Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as HOB . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 117873.0 | |||
| Daily Balance Of Power | 0.1669 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 110.9 | |||
| Day Typical Price | 111.08 | |||
| Price Action Indicator | 1.23 | |||
| Period Momentum Indicator | 1.35 |
About HOB Biotech Buy or Sell Advice
When is the right time to buy or sell HOB Biotech Group? Buying financial instruments such as HOB Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having HOB Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.